查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1972103

超音波針市場：按產品類型、規格、應用和最終用戶分類 - 2026-2032年全球預測

Endoscopic Ultrasound Needles Market by Product Type, Gauge, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，內視鏡超音波針市場價值將達到 1.8591 億美元，到 2026 年將成長至 1.9848 億美元，到 2032 年將達到 2.8699 億美元，複合年成長率為 6.39%。

主要市場統計數據
基準年 2025 1.8591億美元
預計年份：2026年 1.9848億美元
預測年份 2032 2.8699億美元
複合年成長率 (%) 6.39%

為策略決策者提供關於重塑內視鏡超音波針市場的不斷變化的臨床、技術和商業性因素的簡明概述。

內視鏡超音波針在胃腸病學、呼吸內科和腫瘤學領域發揮著至關重要的作用，彌合了診斷準確性和微創治療之間的差距。影像品質的提高、組織取樣技術的進步以及與周邊設備的整合，不斷提升了臨床醫生對這些設備的期望，推動了設計、材料科學和手術流程的創新。臨床醫生日益關注可靠的組織學取樣、與分子分析的兼容性以及能夠在保障患者安全的同時縮短手術時間。因此，產品開發、臨床實踐、採購和醫院管理等相關人員必須應對不斷變化的臨床終點和經濟需求。

技術的整合、流程的標準化以及不斷變化的臨床期望，共同重新定義了設備設計、培訓和商業性重點。

內視鏡超音波針領域正經歷著一場變革，其驅動力包括技術融合、操作流程標準化以及人們對更精準診斷日益成長的需求。穿刺針的設計不再局限於簡單的規格和形狀選擇，而是涵蓋了先進的工程技術、針芯創新以及採用分子保存最佳化的材料。這些設備層面的改進與先進的顯像模式和軟體工具相結合，為內視鏡醫師提供即時回饋，從而降低取樣變異性，並提高組織取樣的可靠性。

對 2025 年關稅調整對醫療設備。

近期影響醫療設備的關稅政策和貿易措施，為依賴國際供應鏈的製造商、經銷商和醫療保健系統帶來了新的挑戰。 2025年的關稅調整改變了部分進口零件和成品的到岸成本，迫使採購團隊重新評估其籌資策略和庫存緩衝。這些政策變化不僅直接影響單價，也凸顯了考慮總到岸成本（包括運費、關稅和運輸時間風險）的重要性。提前建立關稅情境模型的企業在與供應商談判合約、外匯風險以及最佳化配送中心方面更具優勢。

對抽吸針和切片穿刺針的使用案例進行清晰的細分，可以指導產品設計、臨床證據策略和商業性定位。

細分市場分析能夠明確臨床需求與產品功能最契合的領域，有助於確定研發和商業化工作的優先順序。根據產品類型，市場被分類為細針穿刺針和細針活體組織切片針兩大類。細針穿刺針在以細胞學為中心的臨床工作流程中仍然十分有用，因為這類流程優先考慮的是快速現場評估和細胞採集量。另一方面，細針活體組織切片針在組織結構保存和與分子檢測的兼容性至關重要的場景中越來越受歡迎。這種差異會影響器械的特性，例如管腔設計、針尖形狀和組織保留能力。

美洲、歐洲、中東和非洲以及亞太地區面臨的區域差異化挑戰正在決定採用率、監管策略和商業性重點。

區域趨勢在全球範圍內對臨床實踐模式、監管路徑、報銷框架和供應鏈結構的影響各不相同。在美洲，手術量、醫院網路和私人保險模式會影響採購週期以及對那些展現出手術效率和明確臨床價值的器械的優先選擇。臨床醫生的訓練路徑以及與學術研究機構的合作會影響新型針頭技術的早期應用，而區域報銷政策則可能根據證據閾值加速或限制其應用。

產品系列的深度、有針對性的臨床證據和策略性商業夥伴關係如何影響競爭優勢和市場接受度？

內視鏡超音波針領域的競爭動態以快速漸進式創新、策略夥伴關係以及日益重視提供臨床差異化證據為特徵。領先的供應商傾向於投資於產品線的深度拓展（提供各種規格、針尖形狀和配件），同時致力於擴展臨床支援體系，以縮短學習曲線。與學術機構、介入性內視鏡學會和病理學團體開展合作十分普遍，這使得製造商能夠收集可靠的臨床數據，並根據實際操作經驗改進使用說明。

為開發人員、臨床領導者和採購團隊提供可操作的策略方法，以加快部署速度、降低供應風險並展現臨床價值。

產業領導者應採取多管齊下的方法，將產品創新、切實可行的商業策略和臨床合作結合。首先，優先考慮能夠顯著提高下游分子檢測組織品質的設備功能，並使產品宣稱和臨床研究與這些功能性宣稱保持一致。其次，投資於醫生培訓項目，包括模擬、指導和能力評估，以加快安全部署並減少結果的差異。第三，制定報銷材料和衛生經濟學分析，量化手術效率的提升和潛在的再治療減少，以支持與支付者和醫院採購團隊進行價值評估的討論。

採用以證據為導向的混合方法，結合臨床文獻整合、相關人員訪談和供應鏈分析，以檢驗策略見解。

本分析的調查方法結合了對臨床文獻、監管申報文件和器械標籤的系統性回顧，以及有針對性的初步調查，以檢驗關鍵主題。在整合臨床證據時，我們將重點放在報告診斷效用、分子檢測組織合格和併發症率的隨機對照試驗，以及前瞻性註冊研究和高品質隊列分析。監管路徑分析納入了上市前申報摘要和上市後監測數據，以確定不同司法管轄區通用的證據要求和時間節點的考量。

一項簡潔、綜合的分析，結合了技術進步、不斷發展的臨床實務和採購要求，指導下一個策略重點。

總而言之，內視鏡超音波針市場正處於一個轉折點，設計創新、實證臨床應用和穩健的供應鏈實踐在此交匯融合。能夠保護組織結構以進行現代分子診斷的設備層面改進不再是差異化因素，而是成為基本要求。同時，對操作流程標準化和臨床醫生能力的投入對於實現創新穿刺針所承諾的臨床效益至關重要。商業性成功取決於產品宣稱與嚴謹的臨床數據相符，並在操作效率和診斷準確性方面展現出實際價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 內視鏡超音波針市場：依產品類型分類

  • 穿刺切片穿刺針
  • 細針吸針
  • 細針切片針

第9章 內視鏡超音波針市場（依規格分類）

  • 19號口徑
  • 22號口徑
  • 25號口徑

第10章 內視鏡超音波針市場：依應用領域分類

  • 消化道
  • 肝臟疾病及鄰近病變
  • 肺/支氣管/縱膈
  • 淋巴結評估
  • 胰臟疾病

第11章 內視鏡超音波針市場：依最終用戶分類

  • 門診手術中心
  • 診斷檢查室/診斷影像中心
  • 醫院
  • 專科診所/診斷中心

第12章 內視鏡超音波針市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 內視鏡超音波針市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 內視鏡超音波針市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國內視鏡超音波針市場

第16章：中國內視鏡超音波針市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advance Medical Designs, Inc.
  • Aspen Surgical
  • Becton, Dickinson, and Company
  • BIRR
  • Boston Scientific Corporation
  • CIVCO Medical Technologies
  • Conmed Corporation
  • Cook Medical LLC
  • ERBE Elektromedizin GmbH
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Geoteck Medical
  • Hologic Inc.
  • HOYA Corporation
  • Medico's Hirata, Inc.
  • Medtronic plc
  • Olympus Corporation
  • SonoTip GmbH
  • US Endoscopy Group, Inc.
Product Code: MRR-2B5802CFEB55

The Endoscopic Ultrasound Needles Market was valued at USD 185.91 million in 2025 and is projected to grow to USD 198.48 million in 2026, with a CAGR of 6.39%, reaching USD 286.99 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 185.91 million
Estimated Year [2026] USD 198.48 million
Forecast Year [2032] USD 286.99 million
CAGR (%) 6.39%

A concise orientation to the evolving clinical, technological, and commercial drivers reshaping the endoscopic ultrasound needles landscape for strategic decision-makers

Endoscopic ultrasound needles occupy a pivotal role at the intersection of diagnostic precision and minimally invasive therapy within gastroenterology, pulmonology, and oncology practice. Advances in imaging fidelity, tissue acquisition techniques, and ancillary device integration have elevated the clinical expectations placed on these devices, driving innovation across design, materials science, and procedural workflows. Clinician demand is increasingly shaped by the need for reliable histologic sampling, molecular profiling compatibility, and devices that reduce procedural time while maintaining patient safety. Consequently, stakeholders from product development, clinical affairs, procurement, and hospital administration must align around evolving clinical endpoints and economic imperatives.

This executive summary synthesizes the most relevant technological, regulatory, and commercial developments affecting endoscopic ultrasound needles. It consolidates evidence from clinical literature, regulatory filings, physician interviews, and supply chain assessments to present a coherent view of near-term and structural shifts. The objective is to help executives and clinical leaders prioritize initiatives that improve diagnostic yield, streamline training, optimize inventory strategies, and position their organizations or product portfolios for sustainable adoption. By focusing on practical implications rather than raw projections, this introduction sets the stage for informed decision-making across product, clinical, and commercial domains.

How technological convergence, procedural standardization, and evolving clinical expectations are collectively redefining device design, training, and commercial priorities

The landscape for endoscopic ultrasound needles is undergoing transformative shifts driven by technological convergence, procedural standardization, and heightened expectations for precision diagnostics. Needle design has evolved beyond simple gauge and geometry choices to incorporate tip engineering, stylet innovations, and materials optimized for molecular preservation. These device-level refinements are being integrated with enhanced imaging modalities and software tools that provide real-time feedback to endoscopists, thereby reducing sampling variability and improving confidence in tissue acquisition.

Concurrently, clinical workflows are adapting to prioritize multidisciplinary collaboration and standardized sampling protocols. Pathology labs demand high-quality cores compatible with next-generation sequencing and immunohistochemistry, prompting manufacturers to refine needle lumen design and sample retrieval mechanisms. Training programs and proctoring have intensified, with simulation-based curricula and competency assessments becoming more common to accelerate safe adoption of novel needle types. From a commercial perspective, procurement teams are emphasizing total procedural cost and value-based metrics, influencing purchasing decisions toward devices that demonstrably reduce repeat procedures and downstream resource utilization. Finally, regulatory scrutiny and reimbursement pathways are maturing, requiring companies to present robust clinical evidence and real-world performance data to support differentiation and adoption.

Assessing the practical operational, sourcing, and commercial consequences of the 2025 tariff adjustments on device cost structures and supply chain resilience

Recent tariff policies and trade actions affecting medical devices have introduced new layers of complexity for manufacturers, distributors, and health systems that rely on transnational supply chains. Tariff adjustments in 2025 altered landed costs for certain imported components and finished products, compelling procurement teams to reassess sourcing strategies and inventory buffers. These policy changes have not only influenced direct unit costs but also amplified the importance of total landed cost considerations, including freight, customs brokerage, and time-in-transit risks. Organizations that proactively modeled tariff scenarios were better positioned to negotiate supplier agreements, hedge currency exposures, and optimize distribution footprints.

In response to tariff-driven cost pressures, some manufacturers accelerated localization of critical components or diversified their supplier base to reduce reliance on single-country sourcing. This strategic pivot often required investments in qualifying alternative suppliers, conducting supplemental regulatory submissions where device modifications were necessary, and updating quality assurance protocols to preserve clinical performance. Health systems experienced cascading effects as procurement teams evaluated the trade-offs between cost, lead time, and clinical consistency. In many cases, these dynamics heightened interest in strategic vendor partnerships and value-based contracting mechanisms that align incentives across the supply chain. The cumulative impact of these shifts underscores the need for integrated commercial and operational planning to maintain access to clinically preferred devices while managing cost volatility.

Clear segmentation distinctions between aspiration and biopsy needle use cases that guide product design, clinical evidence strategy, and commercial positioning

Segmentation considerations provide clarity on where clinical needs and product features align most tightly, and they help prioritize development and commercialization efforts. Based on Product Type, market is studied across Fine Needle Aspiration Needles and Fine Needle Biopsy Needles. Fine Needle Aspiration needles remain relevant for cytology-focused workflows where rapid on-site evaluation and cellular yield are prioritized, while Fine Needle Biopsy needles have gained traction where tissue architecture preservation and compatibility with molecular assays are essential. This differentiation informs device attributes such as lumen design, tip profile, and tissue retention capabilities.

Understanding these product-type distinctions enables stakeholders to align clinical studies, training programs, and reimbursement strategies with real-world use cases. Developers benefit from tailoring design and labeling to the primary procedural intent, whether that is high-sensitivity cytologic sampling or core tissue retrieval for histologic and genomic analysis. Concurrently, sales and clinical education teams should frame product value around the specific procedural and diagnostic outcomes each needle type is engineered to support. By integrating segmentation insights into product roadmaps and clinical engagement plans, organizations can more precisely target investments that improve adoption and clinical utility.

Differentiated regional imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption, regulatory strategy, and commercial focus

Regional dynamics shape clinical practice patterns, regulatory pathways, reimbursement frameworks, and supply chain configurations in distinct ways across the globe. In the Americas, procedural volumes, hospital networks, and private payer models influence procurement cycles and the prioritization of devices that demonstrate procedural efficiency and clear clinical benefit. Clinician training pathways and academic center research collaborations are influential in early adoption of novel needle technologies, while regional reimbursement policies can accelerate or temper uptake depending on evidence thresholds.

In Europe, Middle East & Africa, heterogeneity in regulatory processes and public reimbursement systems creates a mosaic of adoption pathways where regional clinical champions and centralized procurement can have outsized influence. Suppliers often need to navigate multiple national regulatory nuances and align evidence generation with country-level health technology assessment requirements. In the Asia-Pacific region, a mix of mature and emerging healthcare systems drives a divergent set of priorities: some markets emphasize cost-competitive solutions and local manufacturing, while others focus on cutting-edge diagnostics and rapid incorporation of advanced biopsies into cancer care pathways. Overall, regional strategies must be tailored to local clinical practices, regulatory expectations, and procurement behaviors to ensure successful market entry and sustainable adoption.

How product portfolio depth, targeted clinical evidence, and strategic commercial partnerships are shaping competitive advantage and adoption dynamics

Competitive dynamics in the endoscopic ultrasound needle space are characterized by rapid incremental innovation, strategic partnerships, and an increasing emphasis on evidence generation to substantiate clinical differentiation. Leading suppliers tend to invest in product line depth-offering a range of gauges, tip configurations, and ancillary accessories-while also expanding clinical support infrastructure to shorten learning curves. Collaboration with academic centers, interventional endoscopy societies, and pathology groups is common, enabling manufacturers to gather robust clinical data and refine instructions for use based on real-world procedural insights.

At the same time, smaller innovators are introducing disruptive design elements aimed at niche problems, such as enhanced tissue retention, reduced blood contamination, or compatibility with advanced molecular workflows. These entrants often pursue targeted clinical studies to gain footholds in specialized segments before broader commercialization. Distribution partnerships and contract manufacturing relationships play a critical role in scaling production and extending geographic reach, particularly in regions with complex regulatory requirements. For medtech companies and health system procurement teams, competitive strategy must therefore balance sustained R&D investment, targeted clinical evidence generation, and operational readiness to support broad clinician adoption.

Actionable strategic initiatives for developers, clinical leaders, and procurement teams to accelerate adoption, mitigate supply risk, and demonstrate clinical value

Industry leaders should adopt a multi-pronged approach that combines product innovation with pragmatic commercial tactics and clinical engagement. First, prioritize device features that demonstrably improve tissue quality for downstream molecular testing, and align labeling and clinical studies with those functional claims. Second, invest in physician training programs that include simulation, proctoring, and competency assessments to accelerate safe uptake and reduce variability in outcomes. Third, develop reimbursement dossiers and health economic narratives that quantify procedural efficiency gains and potential reductions in repeat procedures to support value discussions with payers and hospital procurement teams.

Operationally, firms should diversify sourcing strategies for critical components and pursue regional manufacturing or qualified secondary suppliers to mitigate tariff and logistics risk. Commercial teams will be most effective when they couple clinical evidence with practical implementation support-such as starter kits, inventory planning tools, and joint clinical audits-to lower barriers to adoption. Finally, explore strategic partnerships with pathology service providers and molecular diagnostics firms to create bundled solutions that simplify workflows for end-users and strengthen the value proposition across diagnostic pathways. Taken together, these steps will accelerate clinical acceptance, optimize procurement conversations, and reinforce long-term competitive positioning.

An evidence-driven mixed-methods approach combining clinical literature synthesis, stakeholder interviews, and supply chain analysis to validate strategic insights

The research methodology underpinning this analysis combined a structured review of clinical literature, regulatory filings, and device labeling with targeted primary research to validate key themes. Clinical evidence synthesis emphasized randomized studies, prospective registries, and high-quality cohort analyses that reported on diagnostic yield, tissue adequacy for molecular assays, and complication rates. Regulatory pathway analysis incorporated published summaries of premarket submissions and post-market surveillance data to identify common evidence expectations and timing considerations across jurisdictions.

Primary research included semi-structured interviews with practicing endoscopists, pathologists, hospital procurement leaders, and device development professionals to capture frontline perspectives on device performance, training needs, and procurement priorities. Supply chain assessments evaluated typical sourcing footprints, lead-time sensitivities, and the operational implications of tariff and logistics shifts. Finally, findings were triangulated across data sources and subjected to internal validation checks to ensure consistency and to highlight areas where evidence gaps remain. Limitations include variability in reporting across clinical studies and the evolving nature of regulatory guidance that may change the evidentiary bar over time.

A concise synthesis that integrates technological progress, clinical practice evolution, and procurement imperatives to guide next-step strategic priorities

In sum, the endoscopic ultrasound needle landscape is at an inflection point where design innovation, evidence-based clinical adoption, and resilient supply chain practices intersect. Device-level enhancements that preserve tissue architecture for modern molecular diagnostics are becoming foundational requirements rather than optional differentiators. At the same time, procedural standardization and investment in clinician competency are necessary to realize the clinical benefits that innovative needles promise. Commercial success will hinge on aligning product claims with rigorous clinical data and on demonstrating tangible value in procedural efficiency and diagnostic accuracy.

Strategic leaders must therefore adopt integrated approaches that combine focused R&D, targeted evidence generation, and pragmatic operational planning. By doing so, manufacturers and health systems can reduce variability in diagnostic outcomes, optimize procurement decisions, and position themselves to respond rapidly to regulatory and policy shifts. The path forward is collaborative: valuing interdisciplinary clinical feedback, investing in real-world studies, and building supply chain flexibility will provide the most sustainable route to improved patient care and long-term commercial viability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopic Ultrasound Needles Market, by Product Type

  • 8.1. Core Biopsy Needles
  • 8.2. Fine Needle Aspiration Needles
  • 8.3. Fine Needle Biopsy Needles

9. Endoscopic Ultrasound Needles Market, by Gauge

  • 9.1. 19 Gauge
  • 9.2. 22 Gauge
  • 9.3. 25 Gauge

10. Endoscopic Ultrasound Needles Market, by Application

  • 10.1. Gastrointestinal Tract
  • 10.2. Liver Diseases and adjacent lesions
  • 10.3. Lung / Bronchial & Mediastinal
  • 10.4. Lymph Node Assessment
  • 10.5. Pancreatic Diseases

11. Endoscopic Ultrasound Needles Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Laboratories / Imaging Centres
  • 11.3. Hospitals
  • 11.4. Specialty Clinics / Diagnostic Centres

12. Endoscopic Ultrasound Needles Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Endoscopic Ultrasound Needles Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Endoscopic Ultrasound Needles Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Endoscopic Ultrasound Needles Market

16. China Endoscopic Ultrasound Needles Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advance Medical Designs, Inc.
  • 17.6. Aspen Surgical
  • 17.7. Becton, Dickinson, and Company
  • 17.8. BIRR
  • 17.9. Boston Scientific Corporation
  • 17.10. CIVCO Medical Technologies
  • 17.11. Conmed Corporation
  • 17.12. Cook Medical LLC
  • 17.13. ERBE Elektromedizin GmbH
  • 17.14. FUJIFILM Holdings Corporation
  • 17.15. GE HealthCare Technologies Inc.
  • 17.16. Geoteck Medical
  • 17.17. Hologic Inc.
  • 17.18. HOYA Corporation
  • 17.19. Medico's Hirata, Inc.
  • 17.20. Medtronic plc
  • 17.21. Olympus Corporation
  • 17.22. SonoTip GmbH
  • 17.23. US Endoscopy Group, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY CORE BIOPSY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY CORE BIOPSY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY CORE BIOPSY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE BIOPSY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE BIOPSY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE BIOPSY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 19 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 19 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 19 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 22 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 22 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 22 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 25 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 25 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 25 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GASTROINTESTINAL TRACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GASTROINTESTINAL TRACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GASTROINTESTINAL TRACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LIVER DISEASES AND ADJACENT LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LIVER DISEASES AND ADJACENT LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LIVER DISEASES AND ADJACENT LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LUNG / BRONCHIAL & MEDIASTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LUNG / BRONCHIAL & MEDIASTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LUNG / BRONCHIAL & MEDIASTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LYMPH NODE ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LYMPH NODE ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LYMPH NODE ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PANCREATIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PANCREATIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PANCREATIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES / IMAGING CENTRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES / IMAGING CENTRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES / IMAGING CENTRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY SPECIALTY CLINICS / DIAGNOSTIC CENTRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY SPECIALTY CLINICS / DIAGNOSTIC CENTRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY SPECIALTY CLINICS / DIAGNOSTIC CENTRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GCC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GCC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. GCC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 101. GCC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. GCC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. G7 ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. G7 ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. G7 ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 116. G7 ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. G7 ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NATO ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NATO ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NATO ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 121. NATO ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NATO ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 132. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)